NOVA Chemicals Names Byron Romain as General Counsel

Pittsburgh, PA, March 03, 2020 (GLOBE NEWSWIRE) — NOVA Chemicals Corporation (“NOVA Chemicals”) today announced Byron Romain will join the company as Vice President and General Counsel. In this role, he will be responsible for leading all operations of legal including in-house attorneys, external legal affairs, intellectual property rights, corporate and commercial matters, compliance and governance. Byron succeeds Bill Mitchell, who recently retired.

“Byron is a seasoned attorney that brings deep industry experience that will serve us well as we continue to build on our position as a leading player in the North American petrochemical market. We are thrilled to welcome Byron to NOVA Chemicals and look forward to working together to further our purpose of shaping a better world,” stated Todd Karran, President and CEO.

Byron joins NOVA Chemicals from White & Case where he was a partner focused on the upstream and midstream sectors. He has extensive global industry experience in both private practice and as in-house counsel with companies including Marathon Oil and Mubadala Development Company.


About NOVA Chemicals  
NOVA Chemicals develops and manufactures chemicals and plastic resins that make everyday life safer, healthier and easier. Our employees work to ensure health, safety, security and environmental stewardship through our commitment to sustainability and Responsible Care®. NOVA Chemicals, headquartered in Calgary, Alberta, Canada, is wholly-owned, ultimately by Mubadala Investment Company of the Emirate of Abu Dhabi, United Arab Emirates.

For further information, please contact:

Media Relations
Jennifer Nanz
Director, Corporate Communications

Investor Relations
Patty Masry
Financial Reporting & Investor Relations Manager

NOVA Chemicals’ logo is a registered trademark of NOVA Brands Ltd.; authorized use.
Responsible Care® is a registered trademark of the Chemistry Industry Association of Canada.


Comments are closed.

Free newsletter for stock pics, interview transcripts & investing ideas